Reporting guideline provided for? (i.e. exactly what the authors state in the paper)
Reporting the chemical composition of medicinal plant extracts used in pharmacological, toxicological and clinical research studies.
Full bibliographic reference
Heinrich M, Jalil B, Abdel-Tawab M, Echeverria J, Kulić Ž, McGaw LJ, Pezzuto JM, Potterat O, Wang JB. Best Practice in the chemical characterisation of extracts used in pharmacological and toxicological research-The ConPhyMP-Guidelines. Front Pharmacol. 2022;13:953205.
Language
English
PubMed ID
Relevant URLs (full-text if available)
Read the full-text of the ConPhyMP reporting guideline.
Reporting guideline acronym
ConPhyMP
Study design
Clinical trials, Experimental studies
Clinical area
Complementary and alternative medicine, Pharmaceutical medicine, Toxicology
Applies to the whole report or to individual sections of the report?
Harms/adverse effects/safety data, Intervention (exposure), Terminology/definitions
Additional information
An online fillable open-access ConPhyMP tool is also available via the GA (Society of Medicinal Plants and Natural Products Research) website at https://ga-online.org/best-practice/
Record last updated on
August 16, 2023
Training
The UK EQUATOR Centre runs training on how to write using reporting guidelines.